Ditching the Heat: How Sepilife™ NEOS Solves India’s Microplastic and Cold-Process Bottlenecks

Indian formulators face an urgent challenge: eliminate synthetic microplastics, trim factory power bills, and satisfy strict Central Drugs Standard Control Organisation (CDSCO) audits—all without degrading product aesthetics. For years, standard emulsification has relied on energy-intensive thermal tanks and acrylic polymers. It is slow, carbon-heavy, and increasingly at odds with clean beauty mandates.

Sepilife™ NEOS offers a direct fix. By embedding plant-derived bio-squalane into a pre-dispersed liquid polymer network, this hybrid matrix enables stable, cold-process emulsions that drop straight into existing production lines without sacrificing sensory elegance.

Bench Mechanics and Formulation Physics

At the R&D bench, Sepilife™ NEOS eliminates the need to melt heavy wax phases or hydrate stubborn gums over high heat. Instead of battling fish-eyes or long dispersion cycles, formulators simply charge the vessel with cold water, add the liquid polymer under moderate agitation, and let the dual-action mechanism work.

Key performance realities at the bench include:

High Oil-Phase Loading: Holds up to 35% oil phase without adding secondary co-surfactants or heat, keeping emulsions stable across a broad viscosity range (15,000 to 45,000 cPs).

Steric & Hydrodynamic Protection: The pre-dispersed polymer scaffold wraps around oil droplets, preventing coalescence and phase separation over long-term stability testing.

Instant "Quick-Break" Action: Shear during application breaks the polymer scaffold instantly. It releases the aqueous phase on contact, giving consumers an immediate hydrating surge with zero stringiness or tack.

Cohesive Lipid Barrier: As the water breaks, the entrapped bio-squalane deposits evenly across the stratum corneum, leaving a light lipid barrier that reinforces skin health.

CDSCO Regulatory Alignment and Global Export Readiness

Navigating regulatory filings often stalls commercial launches. Sepilife™ NEOS simplifies compliance for domestic manufacturing and global export alike:

CDSCO & IS 4707 Alignment: Completely Ethylene Oxide (EO)-free, the raw material eliminates trace 1,4-dioxane safety concerns. This simplifies toxicological dossiers for Form COS-1 and Form COS-2 import registrations.

ECHA Microplastic Compliance: Designed to pass European Chemicals Agency (ECHA) microplastic restrictions, giving Indian contract manufacturers an export-ready chassis for EU and US retail channels.

Commercial & Operational Impact for CMOs and Brands

Switching from traditional hot-process emulsification to a cold-process hybrid matrix yields immediate operational returns for both contract manufacturers and brand owners.

Operational Gains for Plant Managers

Batch Cycle Reduction: Cutting out thermal cycles slashes total batch times by up to 60%. Operators no longer wait hours to heat vessels to 80°C and cool them back down.

Faster Vessel Clean-Down: Cold-water dispersion speeds up vessel washouts between production runs, cutting water usage and caustic detergent costs.

Decarbonisation & Capacity: Eliminating thermal energy directly reduces Scope 1 and Scope 2 carbon emissions while expanding annual plant processing throughput without added capital expenditure.

Strategic Advantages for Brand Owners

ISO 16128 Compliance: Delivers over 65% Natural Origin Content, providing verified natural positioning claims.

Formula Simplification: Replaces complex, multi-component stabilizer systems with a single multifunctional liquid chassis, streamlining raw material inventory.

Versatile Texture Options: Ideal for formulating fast-break serums, lightweight gel-creams, fluid sunscreens, and delicate post-dermatological treatments.

Adopting Sepilife™ NEOS is more than an eco-conscious upgrade—it is a pragmatic operational move. By embracing hybrid squalane-polymer technology, R&D teams can bypass traditional manufacturing bottlenecks, satisfy stringent global standards, and bring high-performance, microplastic-free formulas to market faster.